A separate investigation has provided evidence that SCNN1A is associated with unfavorable clinical outcomes in individuals afflicted with ovarian cancer, and exerts an impact on the immune cell infiltration patterns within the tumor microenvironment (Lou et al., 2022). Here, SCNN1A is linked to ovarian cancer.